Position in JAZZ
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$548,241,690
+$97,009,588 QoQ
Shares Held
2,275,145
-4.7% QoQ
Ownership
3.50%
of shares outstanding
% of Portfolio
1.00%
of 13F equity value
Holder Rank
#6
of 640 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 68%
Shared 0%
None 32%
Common Shares in JAZZ Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026LSV ASSET MANAGEMENT holds $1,914,392,782 across 14 Biotechnology names. JAZZ ranks #1 (28.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
This page
|
2,275,145 | $548,241,690 | |
| 2 | INCY |
Incyte Corp
|
4,123,759 | $467,469,320 | |
| 3 | EXEL |
Exelixis, Inc.
|
8,146,478 | $443,249,867 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
253,200 | $157,880,328 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
1,410,257 | $110,380,815 | |
| 6 | HRMY |
Harmony Biosciences Holdings, Inc.
|
2,061,242 | $75,049,821 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
881,700 | $50,450,874 | |
| 8 | RIGL |
Rigel Pharmaceuticals Inc
|
721,666 | $28,231,573 |
All Filings in JAZZ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $548,241,690 | 2,275,145 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $451,232,102 | 2,386,840 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $417,512,690 | 2,455,957 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $331,062,884 | 2,511,858 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $271,003,101 | 2,553,742 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $306,174,508 | 2,466,166 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $311,698,807 | 2,531,050 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $277,850,078 | 2,493,942 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $264,750,488 | 2,480,563 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $286,702,920 | 2,380,858 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $288,216,921 | 2,343,227 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $307,054,590 | 2,372,177 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $287,182,331 | 2,316,547 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $339,251,910 | 2,318,403 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $327,524,473 | 2,055,894 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $234,720,624 | 1,760,977 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $270,161,424 | 1,731,693 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $281,450,114 | 1,807,992 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $234,043,482 | 1,837,076 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $244,569,015 | 1,878,266 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $350,983,954 | 1,975,816 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $340,635,621 | 2,072,371 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $374,585,431 | 2,269,527 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $348,056,058 | 2,440,957 | Shares | Sole | 2020-10-23 | |
| 2020-06-30 | $245,554,056 | 2,225,431 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $185,757,371 | 1,862,416 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||